- Investigator
- Thomas J George
Clinical trials
-
Gemcitabine with Abraxane and other Therapies in Neoadjuvant Treatment of Pancreatic Cancer -
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors This phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors. Chemotherapy drugs, such as capecitabine and temozolomide, work in…
- Investigator
- Brian H Ramnaraign
- Ages
- 18 Years - N/A
- Sexes
- All
-
PAN009-18 (PC04): Protons for Unresectable, Borderline Resectable, or Medically Inoperable Panc The prognosis for patients with localized pancreatic adenocarcinoma who are not surgical candidates is poor. Patients characterized as having "borderline resectable" disease treated with preoperative chemo-radiotherapy fair somewhat better *…
- Investigator
- Romaine C Nichols
- Ages
- 18 Years - N/A
- Sexes
- All